Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hackensack Meridian Health
University of Iowa
Allogene Therapeutics
Massachusetts General Hospital
Penn State University
Otsuka Pharmaceutical Co., Ltd.
University of Chicago
Hutchmed
CRISPR Therapeutics
Incyte Corporation
M.D. Anderson Cancer Center
Massachusetts General Hospital
Sanofi
Pfizer
Scripps Translational Science Institute
Washington University School of Medicine
Merck Sharp & Dohme LLC
Hutchmed
CytomX Therapeutics
Massachusetts General Hospital
Thomas Jefferson University
Gamida Cell ltd
Dana-Farber Cancer Institute
ADC Therapeutics S.A.
Pfizer
Oncternal Therapeutics, Inc
Takeda
Columbia University
Celgene
Columbia University
ModernaTX, Inc.
Altor BioScience
Wake Forest University Health Sciences
EMD Serono
Pfizer
University of Virginia
Synlogic
Memorial Sloan Kettering Cancer Center
Eisai Inc.
OHSU Knight Cancer Institute
Bayer
ADC Therapeutics S.A.
University of Nebraska
City of Hope Medical Center
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group